ANGPTL3 is a hepatokine that inhibits lipoprotein and endothelial lipases, and human loss-of-function and pharmacologic antagonism lower triglycerides and low-density lipoprotein and are associated with reduced coronary disease risk34,35. The gene discussed is LIPG; the disease is coronary artery disorder.